Coca-Cola Co. raised its quarterly dividend to 42 cents a share, up 2.4 percent from an already relatively high dividend of 41 cents to mark the 59th straight year of dividend increments.
Its shares went up nearly 1.3 percent to $50.77 at the close of trading on Feb. 18. The new quarterly dividend is payable on April 1 to stockholders of record on March 15.
Coca-Cola Co. made the increase a week after reporting that it calculated a potential liability of around $12 billion resulting from the application of the Internal Revenue Service (IRS)'s proposed transfer pricing methodology to foreign licensees through Dec. 31, 2020.
The company disclosed the potential tax hit on its fourth quarter and full-year 2020 results.
The Atlanta-based soft drink company noted that the US Tax Court "predominantly" sided with the IRS on the issue of transfer pricing or licensing of the intangible property of its brand names and formulas to its foreign licensees.
However, the company said it will ultimately prevail in the case based on the technical and legal merits of its position, its consultation with outside advisors, and the unconstitutionality of the IRS' retroactive imposition of tax liability.


Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 



